FierceBiotech and its family of publications provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way. We track tiny, virtual startups and the biggest of Big Pharma, highlighting the accomplishments and acknowledging the defeats that all of them experience on their way to market with a new therapy or device. The FierceBiotech team transcends the daily as well, with comprehensive coverage of key medical meetings plus special reports that highlight up-and-comers and shed new light on industry heavyweights.
Every business day, FiercePharma updates pharmaceutical executives on company news and earnings, FDA regulations, drug safety, generic drug companies, and more. Beyond the news of the day, our editors produce in-depth features on industry leaders and market trends. As a member of our community, you will receive an exclusive invitation to each of our webinars and gain full access to our entire white paper and eBook library. Advance your career by attending our networking parties and taking full advantage of our job board. Visit our website and start receiving our free FiercePharma email newsletter!
American Pharmaceutical Review is the leading review journal for business and technology in the pharmaceutical industry throughout North America. Each issue offers American Pharmaceutical Review's 30,000 readers unbiased editorial coverage of the latest developments in: drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. With its in-depth coverage, American Pharmaceutical Review is able to keep its readership of senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.